Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China

Clinical Microbiology and Infection

Volumn 18, Issue 12, 2012, Pages

  Yang, J ^a   Chen, Y ^b   Jia, X ^b   Luo, Y ^a   Song, Q ^a   Zhao, W ^b   Wang, Y ^b   Liu, H ^a   Zheng, D ^b   Xia, Y ^b   Yu, R ^b   Han, X ^b   Jiang, G ^b   Zhou, Y ^b   Zhou, W ^b   Hu, X ^b   Liang, L ^b   Han, L ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Acinetobacter pittii; Insertion sequence element; Intensive care unit; NDM 1; Sequence type 63

Indexed keywords

AMIKACIN; CARBAPENEM; CARBAPENEMASE; CIPROFLOXACIN; ERTAPENEM; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE 1; UNCLASSIFIED DRUG;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER PITTII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHILD; CHINA; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE INSERTION SEQUENCE; HEALTH CARE PERSONNEL; HUMAN; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PLASMID; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SCHOOL CHILD;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ESCHERICHIA COLI;

EID: 84869101418     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12035     Document Type: Article

References (43)

1. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011; 11: 355-362.
2. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
3. Walsh TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 2010; 36 (Suppl 3): S8-S14.
4. Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol 2011; 19: 588-595.
5. Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother 2010; 65: 2253-2254.
6. Espinal P, Fugazza G, Lopez Y et al. Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli Rehabilitation Center. Antimicrob Agents Chemother 2011; 55: 5396-5398.
7. Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother 2011; 66: 1260-1262.
8. Pfeifer Y, Wilharm G, Zander E et al. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother 2011; 66: 1998-2001.
9. Chen Y, Zhou Z, Jiang Y, Yu Y. Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother 2011; 66: 1255-1259.
10. Poirel L, Schrenzel J, Cherkaoui A, Bernabeu S, Renzi G, Nordmann P. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J Antimicrob Chemother 2011; 66: 1730-1733.
11. Sole M, Pitart C, Roca I et al. First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob Agents Chemother 2011; 55: 4402-4404.
12. Ghazawi A, Sonnevend A, Bonnin RA et al. Ndm-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates. Clin Microbiol Infect 2012; 18: E34-E36.
13. Toleman MA, Spencer J, Jones L, Walsh TR. blaNDM-1 is a chimera, likely constructed in Acinetobacter baumanii. Antimicrob Agents Chemother 2012; 56: 2773-2776.
14. Poirel L, Bonnin RA, Boulanger A, Schrenzel J, Kaase M, Nordmann P. Tn125-related acquisition of blandm-like genes in Acinetobacter baumannii. Antimicrob Agents Chemother 2012; 56: 1087-1089.
15. Hu H, Hu Y, Pan Y et al. Novel plasmid and its variant harboring both blaNDM-1 gene and type IV secretion system in clinical isolates of Acinetobacter lwoffii. Antimicrob Agents Chemother 2012; 56: 1698-1702.
16. Boo TW, Walsh F, Crowley B. Molecular characterization of carbapenem-resistant acinetobacter species in an Irish University Hospital: predominance of acinetobacter genomic species 3. J Med Microbiol 2009; 58: 209-216.
17. Houang ET, Chu YW, Leung CM et al. Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong. J Clin Microbiol 2001; 39: 228-234.
18. Chu YW, Leung CM, Houang ET et al. Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol 1999; 37: 2962-2967.
19. Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of acinetobacter species. J Clin Microbiol 1991; 29: 277-282.
20. Nemec A, Krizova L, Maixnerova M et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. Nov. (formerly acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. Nov. (formerly acinetobacter genomic species 13tu). Res Microbiol 2011; 162: 393-404.
21. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005; 43: 1632-1639.
22. Meng X, Dong M, Wang DI et al. Antimicrobial susceptibility patterns of clinical isolates of gram-negative bacteria obtained from intensive care units in a tertiary hospital in Beijing, China. J Chemother 2011; 23: 207-210.
23. Chen Y, Cui Y, Pu F et al. Draft genome sequence of an acinetobacter genomic species 3 strain harboring a bla(NDM-1) gene. J Bacteriol 2012; 194: 204-205.
24. Zhou Z, Guan R, Yang Y et al. Identification of new delhi metallo-beta-lactamase gene (NDM-1) from a clinical isolate of Acinetobacter junii in China. Can J Microbiol 2012; 58: 112-115.
25. Wang Y, Wu C, Zhang Q et al. Identification of new delhi metallo-beta-lactamase 1 in Acinetobacter lwoffii of food animal origin. PLoS ONE 2012; 7: e37152.
26. Fu Y, Du X, Ji J, Chen Y, Jiang Y, Yu Y. Epidemiological characteristics and genetic structure of blaNDM-1 in non-baumannii Acinetobacter spp. in China. J Antimicrob Chemother 2012; 67: 2114-2122.
27. Prashanth K, Badrinath S. Simplified phenotypic tests for identification of Acinetobacter spp. and their antimicrobial susceptibility status. J Med Microbiol 2000; 49: 773-778.
28. La Scola B, Gundi VA, Khamis A, Raoult D. Sequencing of the rpob gene and flanking spacers for molecular identification of acinetobacter species. J Clin Microbiol 2006; 44: 827-832.
29. Woodford N, Ellington MJ, Coelho JM et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27: 351-353.
30. Mendes RE, Kiyota KA, Monteiro J et al. Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J Clin Microbiol 2007; 45: 544-547.
31. CLSI. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement (m100-s22). Clin Lab Stand Inst, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA 2012; 32: 64-65.
32. Hamouda A, Evans BA, Towner KJ, Amyes SG. Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes. J Clin Microbiol 2010; 48: 2476-2483.
33. Aziz RK, Bartels D, Best AA et al. The RAST server: rapid annotations using subsystems technology. BMC Genomics 2008; 9: 75.
34. McGinnis S, Madden TL. BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res 2004; 32: W20-W25.
35. Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P, Carattoli A. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 2010; 54: 4168-4177.
36. Rieck B, Tourigny DS, Crosatti M et al. Acinetobacter insertion sequence ISAba11 belongs to a novel family that encodes transposases with a signature HHEK motif. Appl Environ Microbiol 2012; 78: 471-480.
37. Smith MG, Gianoulis TA, Pukatzki S et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 2007; 21: 601-614.
38. Allen KD, Green HT. Hospital outbreak of multi-resistant acinetobacter anitratus: an airborne mode of spread?J Hosp Infect 1987; 9: 110-119.
39. Bernards AT, Frenay HM, Lim BT, Hendriks WD, Dijkshoorn L, van Boven CP. Methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii: an unexpected difference in epidemiologic behavior. Am J Infect Control 1998; 26: 544-551.
40. Xie X, Li Y, Zhang T, Fang HH. Bacterial survival in evaporating deposited droplets on a teflon-coated surface. Appl Microbiol Biotechnol 2006; 73: 703-712.
41. Xiao YH, Giske CG, Wei ZQ, Shen P, Heddini A, Li LJ. Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat 2011; 14: 236-250.
42. Bonomo RA. New Delhi metallo-beta-lactamase and multidrug resistance: a global SOS?Clin Infect Dis 2011; 52: 485-487.
43. Moffatt JH, Harper M, Adler B, Nation RL, Li J, Boyce JD. Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob Agents Chemother 2011; 55: 3022-3024.